Harry P. Erba, MD, PhD

My Locations

Duke Cancer Center
20 Duke Medicine Circle
Durham, NC 27710

About Me

I entered medical school for the sole purpose of learning more about human diseases, so that I could focus my laboratory efforts on improving the human condition. However, I was surprised to find myself drawn to clinical care. I care for people afflicted by acute leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. In this role, I have had the privilege of treating people facing life-threatening illnesses. I strive to gain the trust of each of my patients, so that I can help them make difficult treatment decisions. I engage in clinical research, evaluating novel agents that directly target the cancer cell to improve the degree of success in treating this illness. My patients benefit from my understanding of the newest available treatments, and also have access to promising investigational agents, when appropriate. In my faculty position at Duke University, I enjoy educating current oncologists as well as the next generation of physicians.

Languages
English
Learn More About Me
My surgical specialties
Procedures I perform the most

Training

Education
MD, Stanford University School of Medicine (California), 1988
Residency
Internal Medicine, Brigham and Women's Hospital (Massachusetts), 1988-1990
Fellowship
Hematology-Oncology, Harvard Medical School, Brigham & Women's Hospital (Massachusetts), 1990-1993
Board Certifications
American Board of Internal Medicine, Hematology

Clinical Focus and Research

My Research Interests

I treat people with acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPN). In general, therapies initially developed for these cancers were drugs that killed cells that are dividing. Unfortunately, many normal cells in the body are also affected or killed by these drugs as well, leading to the unwanted toxicities of chemotherapy. Over the years, we have gained tremendous insight into the specific events that cause a cell to become cancerous and have developed better tools for distinguishing normal from cancerous cells. My clinical research effort for over 20 years has focused on the development of drugs that specifically target the abnormalities of the leukemia cell. I study the effects associated with treating people with investigational agents that target the molecular changes that are specific to blood cancers. I have been an active member of teams of doctors that have brought new treatments to people with leukemia, such as oral drugs that inactivate FLT3 and IDH. In this way we hope to improve the outcome of people with blood cancers with fewer unwanted side effects.

Publications

View Harry Erba's publications on PubMed

Insurance

Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below. Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.

Below are the plans currently accepted in 2018. There are some changes to the plans accepted beginning January 1, 2019. For a complete list of plans accepted in 2019 and to verify that your health plan includes Duke Health, please visit PlanForDuke.com.

View Accepted Insurance Plans
    • Aetna
      • Aetna Choice POS, Aetna Choice POS II
      • Aetna Elect Choice HMO, Aetna Open Access Elect Choice
      • Aetna Health Network Only, Aetna Health Network Option
      • Aetna HMO
      • Aetna Limited Benefit Insurance PPO
      • Aetna Managed Choice POS
      • Aetna Medicare HMO Open Access
      • Aetna Medicare Plan (HMO, PPO)
      • Aetna Medicare Premier Plan (PPO)
      • Aetna Medicare Prime Plan (HMO, PPO)
      • Aetna Open Access HMO, Open Access Aetna Select, Aetna Open Access Select, Aetna Open Access Managed Choice
      • Aetna Open Choice PPO
      • Aetna PCP Coordinated POS Plan
      • Aetna Quality Point of Service (QPOS)
      • Aetna Select HMO
      • Aetna Traditional Choice
      • Aetna Voluntary Indemnity Group Plan
      • Aetna Whole Health – Duke WakeMed WKCC
    • Blue Cross Blue Shield of NC
      • Blue Advantage
      • Blue Local with Duke Health and WakeMed*
      • Blue Medicare (HMO, PPO)**
      • Blue Options (123, PPO, HSA)
      • Blue Select
      • NC State Employees Health Plan
      • *BCBSNC will no longer offer Blue Local with Duke Health & WakeMed in 2019. Action may be needed on your part. Visit to learn more.
      • **Duke HomeCare and Hospice does not participate in the plan.
    • CIGNA
      • Cigna Choice Plus
      • Cigna Open Access
      • Cigna Open Access Plus
    • Coventry Healthcare
      • Coventry Advantra Freedom (PPO)*
      • Coventry Advantra Gold (HMO)*
      • Dual Option of AWH or PPO*
      • *Coventry Healthcare will no longer be accepted in 2019.
    • Duke Group Plans
      • Duke Basic
      • Duke Select
    • First Health
    • Gateway Health Alliance
    • Gateway Health Plan
      • Gateway Health Medicare Assured Prime (HMO)
      • Gateway Health Medicare Assured Select (HMO)
    • Halifax Physician-Hospital Organization
    • Healthgram
    • Humana
      • Humana Choice (PPO)
      • Humana ChoiceCare (PPO)
      • Humana Gold Choice (PFFS)
      • Humana Gold Plus (HMO)
    • MedCost
    • Medicare
      • First Medicare Direct*
      • Medicare Part A
      • Medicare Part B
      • *This is for Wake County only.
    • MultiPlan / Private Healthcare Systems
    • NC Medicaid
      • NC Medicaid*
      • *Not all Duke locations and doctors participate in this plan. Please contact the location you will be visiting to determine what is accepted.
    • OneNet PPO
    • Optima Health
      • FAMIS
      • Optima Family Care (Medicaid HMO in VA)
      • Optima Individual & Family (On & Off Exchange Plans)
      • Optima Plus (PPO)
      • Optima Vantage (HMO)
    • TRICARE
      • TRICARE Extra*
      • TRICARE for Life*
      • TRICARE Prime*
      • TRICARE Prime Remote*
      • TRICARE Standard*
      • *Duke Primary Care does not participate with the plan.
    • United Healthcare
      • AARP Medicare Complete (HMO, PPO)*
      • AARP Medicare Complete Essential (HMO)*
      • All Savers Alternate Funding
      • All Savers Fully Insured
      • State Employee Health Plan (for retirees)
      • United Healthcare (HMO, PPO, POS)
      • United Healthcare Charter/Charter Balance/Charter Plus
      • United Healthcare Choice/Choice Plus
      • United Healthcare Core/Core Essential
      • United Healthcare Navigate/Navigate Plus/Navigate Balanced
      • United Healthcare of the River Valley
      • United Healthcare Option PPO
      • United Healthcare Options PPO with Harvard Pilgrim
      • United Healthcare Passport Connect Choice/Choice Plus
      • United Healthcare Passport Connect Options PPO
      • United Healthcare Select/Select Plus
      • United Medical Resources (UMR)
      • *Not all Duke hospitals and doctors participate in these plans. Please contact your insurance provider to determine what your financial responsibility will be for the health care service you require.

Industry Relationships and Collaborations

This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

  • AbbVie
  • Agios Pharmaceuticals
  • Celgene Corporation
  • Daiichi Sankyo Co., Ltd
  • Glycomimetics
  • Jazz Pharmaceuticals
  • Novartis
  • Pfizer Inc.
  • incyte